D.J. St. Germain’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
D.J. St. Germain's JAZZ Position: Q2 2026 in Review
D.J. St. Germain held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 324 shares worth $78.1K. The position accounts for ﹤0.01% of the portfolio, ranked #410.
D.J. St. Germain first reported a position in JAZZ in Q2 2023 and has held it in 13 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- D.J. St. Germain held 324 shares of Jazz Pharmaceuticals worth $78.1K as of Q2 2026.
- D.J. St. Germain left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #410 holding.
- D.J. St. Germain first reported a position in Jazz Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.